Systemic autoimmune disorders have a higher prevalence in women, particularly during their childbearing age. A growing interest is being paid to the possible consequences of maternal disease and associated treatment on the fetus and newborn infant. If maternal disease is characterized by the presence of IgG isotype auto-antibodies, these can cross the placenta with possible antibody-mediated damage to the fetus. The risk of gestational complications, including preterm delivery, intrauterine growth retardation and low birth weight is higher in autoimmune diseases rather than in the general population and probably this finding is related to both maternal disorder and immunosuppressive therapy. Recently, results of our studies suggest that the antenatal exposure to immunosuppressive drugs given to mothers during pregnancy to treat autoimmune diseases does not impair significantly the development of immunity in exposed children. Finally, mothers disease and/or treatment could be related to neuropsychological dysfunctions reported in some of their children. © 2009

Motta, M., Rodriguez-Perez, C., Tincani, A., Lojacono, A., Nacinovich, R., Chirico, G. (2009). Neonates born from mothers with autoimmune disorders. EARLY HUMAN DEVELOPMENT, 85(10), S67-S70 [10.1016/j.earlhumdev.2009.08.020].

Neonates born from mothers with autoimmune disorders

Nacinovich, R;
2009

Abstract

Systemic autoimmune disorders have a higher prevalence in women, particularly during their childbearing age. A growing interest is being paid to the possible consequences of maternal disease and associated treatment on the fetus and newborn infant. If maternal disease is characterized by the presence of IgG isotype auto-antibodies, these can cross the placenta with possible antibody-mediated damage to the fetus. The risk of gestational complications, including preterm delivery, intrauterine growth retardation and low birth weight is higher in autoimmune diseases rather than in the general population and probably this finding is related to both maternal disorder and immunosuppressive therapy. Recently, results of our studies suggest that the antenatal exposure to immunosuppressive drugs given to mothers during pregnancy to treat autoimmune diseases does not impair significantly the development of immunity in exposed children. Finally, mothers disease and/or treatment could be related to neuropsychological dysfunctions reported in some of their children. © 2009
Articolo in rivista - Articolo scientifico
Antiphospholipid syndrome, Immunosuppressive agents, Learning disabilities, Newborn, Pregnancy, Systemic lupus Erythematosus
English
2009
85
10
S67
S70
reserved
Motta, M., Rodriguez-Perez, C., Tincani, A., Lojacono, A., Nacinovich, R., Chirico, G. (2009). Neonates born from mothers with autoimmune disorders. EARLY HUMAN DEVELOPMENT, 85(10), S67-S70 [10.1016/j.earlhumdev.2009.08.020].
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0378378209001480-main.pdf

Solo gestori archivio

Descrizione: Articolo principale
Dimensione 141.98 kB
Formato Adobe PDF
141.98 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/22739
Citazioni
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 22
Social impact